Suppr超能文献

鞘氨醇激酶和鞘氨醇-1-磷酸受体 2 在脂多糖诱导的急性视网膜炎症中的作用。

Roles of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor 2 in Endotoxin-Induced Acute Retinal Inflammation.

机构信息

Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.

Department of Ophthalmology & Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, USA.

出版信息

Ocul Immunol Inflamm. 2024 Oct;32(8):1633-1647. doi: 10.1080/09273948.2023.2273963. Epub 2023 Dec 15.

Abstract

PURPOSE

To investigate the roles of sphingosine kinases (SphKs) and sphingosine-1-phosphate receptors (S1PRs) in endotoxin-induced uveitis (EIU) mice.

METHODS

EIU model was induced using an intraperitoneal injection of lipopolysaccharide (LPS). The expression of SphKs and S1PRs in the retina was assessed using quantitative polymerase chain reaction (qPCR) and immunofluorescence. The effects of S1PR antagonists on the expression of inflammatory cytokines in the retina were evaluated using qPCR and western blotting. Effects of leukocyte infiltration of the retinal vessels were evaluated to determine the effects of the S1PR2 antagonist and genetic deletion of on retinal inflammation.

RESULTS

Retinal SphK1 expression was significantly upregulated in EIU. SphK1 was expressed in the GCL, IPL, and OPL and S1PR2 was expressed in the GCL, INL, and OPL. Positive cells in IPL and OPL of EIU retina were identified as endothelial cells. S1PR2 antagonist and genetic deletion of S1PR2 significantly suppressed the expression of IL-1α, IL-6, TNF-α, and ICAM-1, whereas S1PR1/3 antagonist did not. Use of S1PR2 antagonist and knockout in mice significantly ameliorated leukocyte adhesion induced by LPS.

CONCLUSION

SphK1/S1P/S1PR2 signaling was upregulated in EIU and S1PR2 inhibition suppressed inflammatory response. Targeting this signaling pathway has potential for treating retinal inflammatory diseases.

摘要

目的

研究鞘氨醇激酶(SphKs)和鞘氨醇-1-磷酸受体(S1PRs)在脂多糖(LPS)诱导的葡萄膜炎(EIU)小鼠中的作用。

方法

通过腹腔内注射脂多糖(LPS)诱导 EIU 模型。采用定量聚合酶链反应(qPCR)和免疫荧光法检测视网膜中 SphKs 和 S1PRs 的表达。采用 qPCR 和 Western blot 法评估 S1PR 拮抗剂对视网膜中炎症细胞因子表达的影响。通过评估视网膜血管白细胞浸润来评估 S1PR2 拮抗剂和 基因缺失对视网膜炎症的影响。

结果

EIU 时视网膜 SphK1 表达明显上调。SphK1 在 GCL、IPL 和 OPL 中表达,S1PR2 在 GCL、INL 和 OPL 中表达。EIU 视网膜 IPL 和 OPL 中的阳性细胞被鉴定为内皮细胞。S1PR2 拮抗剂和 S1PR2 基因缺失显著抑制了 IL-1α、IL-6、TNF-α 和 ICAM-1 的表达,而 S1PR1/3 拮抗剂则没有。在小鼠中使用 S1PR2 拮抗剂和 基因敲除显著改善了 LPS 诱导的白细胞黏附。

结论

EIU 中 SphK1/S1P/S1PR2 信号通路被上调,S1PR2 抑制抑制了炎症反应。靶向该信号通路可能为治疗视网膜炎症性疾病提供新的治疗策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验